Australia's most trusted
source of pharma news
Saturday, 12 July 2025
Posted 11 July 2025 AM
Forecast drug sales to 2030 reflect solid underlying demand, according to data analytics specialist Evaluate, with Eli Lilly’s Mounjaro tipped to become the top-selling product by a wide margin.
In its World Preview 2025 Report, Evaluate projects that worldwide prescription drug sales will reach over US$1.75 trillion in 2030, representing a compound annual growth of over 7 per cent.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.